Dc Do you know what we find interesting..This is why we think Radient is going to merge with Provista Diagnostics...When the questions to William...William replied with a question..William stated "Before I answer all of your questions, I need to know more about you, especially whether or not you are a qualified investor under Rule 144."...Then William asked ..."Do you represent a firm or is this personal?" What we would like to see now is the reply to William and William's reply to the messenger..Where are the missing emails Lois.. imo Wolf ahoooololoooooo
Good morning,
Before I answer all of your questions, I need to know more about you, especially whether or not you are a qualified investor under Rule 144. I will say this to clear up that very old rumor. We have no connection whatsoever with Radient Pharmaceutical in any way – company-wise or personally.
Do you represent a firm or is this personal? We must be very careful to comply with all of the regulations.
Here are the Questions unanswered..
Provistadx has repeatedly denied any connection with Radient Pharmaceuticals.
William Gartner of GCDx denies any connection with Radient Pharmaceuticals.
Dear Mr. Gartner,
I am intrigued by your recent press release about offering a new Lung Cancer Test.
How do you get your financing? Is there an opportunity for a private investor like me to invest, and if so, how would I accomplish that?
In researching GCDx, I am finding several rumors on the internet (particularly on InvestorsHub.com) that your company is merging with, or taking over, Radient Pharmaceuticals and/or Provista Diagnostics. Is there any truth to that rumor? What is your current business relationship with Radient Pharmaceuticals and Provista Diagnostics? Do you own RXPC stock?
